Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases

被引:1
|
作者
Shadrach, Benhur Joel [1 ]
Dutt, Naveen [1 ]
Elhence, Poonam [2 ]
Banerjee, Mithu [3 ]
Chauhan, Nishant Kumar [1 ]
Jalandra, Ram N. [4 ]
Garg, Mahendra Kumar [5 ]
Garg, Pawan [6 ]
Tandon, Abhishek [1 ]
Shishir, Saumya [1 ]
Kochar, Rishabh [1 ]
Chhatwani, Bhavesh [1 ]
Pareek, Piyush [1 ]
Parrikar, Anika [1 ]
机构
[1] All India Inst Med Sci, Dept Pulm Med, Jodhpur, India
[2] All India Inst Med Sci, Dept Pathol, Jodhpur, India
[3] All India Inst Med Sci, Dept Biochem, Jodhpur, India
[4] All India Inst Med Sci, Dept Pulm Med, Bathinda, India
[5] All India Inst Med Sci, Dept Med, Jodhpur, India
[6] All India Inst Med Sci, Dept Radiol, Jodhpur, India
关键词
krebs von den lungen-6; c-reactive protein; severity; kl-6; neutrophilia; crp; chronic fibrosing interstitial lung diseases; bronchoalveolar lavage; IDIOPATHIC PULMONARY FIBROSIS; C-REACTIVE PROTEIN; KL-6; SERUM; ALVEOLITIS; DIAGNOSIS; DECLINE;
D O I
10.7759/cureus.42162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction It is hypothesized that bronchoalveolar lavage (BAL) neutrophilia, Krebs von den Lungen-6 (KL-6), and C-reactive protein (CRP) predict the severity of chronic fibrosing interstitial lung diseases (CF-ILDs). Methods This cross-sectional study enrolled 30 CF-ILD patients. Using Pearson's correlation analysis, BAL neutrophils, KL-6, and CRP were correlated with forced vital capacity (FVC), diffusing lung capacity for carbon monoxide (DLCO), six-minute walk distance (6MWD), partial pressure of oxygen (PaO2), computed tomography fibrosis score (CTFS), and pulmonary artery systolic pressure (PASP). Using the receiver operator characteristic (ROC) curve, BAL KL-6 and CRP were evaluated against FVC% and DLCO% in isolation and combination with BAL neutrophilia for predicting the severity of CF-ILDs. Results BAL neutrophilia significantly correlated only with FVC% (r = -0.38, P = 0.04) and DLCO% (r = -0.43, P = 0.03). BAL KL-6 showed a good correlation with FVC% (r = -0.44, P < 0.05) and DLCO% (r = -0.50, P = 0.02), while BAL CRP poorly correlated with all parameters (r = 0.0-0.2). Subset analysis of BAL CRP in patients with CTFS <= 15 showed a better association with FVC% (r = -0.28, P = 0.05) and DLCO% (r = -0.36, P = 0.04). BAL KL-6 cut-off >= 72.32 U/ml and BAL CRP >= 14.55 mg/L predicted severe disease with area under the curve (AUC) values of 0.77 and 0.71, respectively. The combination of BAL neutrophilia, KL-6, and CRP predicted severity with an AUC value of 0.89. Conclusion The combination of BAL neutrophilia, KL-6, and CRP facilitates the severity stratification of CF-ILDs complementing existing severity parameters.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The utility of bronchoalveolar lavage in the evaluation of interstitial lung diseases: A clinicopathological perspective
    Gharsalli, Houda
    Mlika, Mouna
    Sahnoun, Imen
    Maalej, Sonia
    El Gharbi, Leila Douik
    El Mezni, Faouzi
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2018, 35 (05) : 280 - 287
  • [2] The clinical utility of bronchoalveolar lavage in interstitial lung disease - is it really useful?
    Meyer, Keith C.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (02) : 133 - 135
  • [3] Diagnostic Utility of Bronchoalveolar Lavage Lymphocytosis in Patients with Interstitial Lung Diseases
    Tzilas, Vasilios
    Digalaki, Antonia
    Bouros, Evangelos
    Avdoula, Eleni
    Tzouvelekis, Argyrios
    Bouros, Demosthenes
    RESPIRATION, 2023, 102 (11) : 944 - 947
  • [4] The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
    Wuyts, Wim A.
    Dooms, Cristophe
    Verleden, Geert M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (07) : 777 - 777
  • [5] Bronchoalveolar lavage in other interstitial lung diseases
    Costabel, Ulrich
    Guzman, Josune
    Bonella, Francesco
    Oshimo, Shinichiro
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (05) : 514 - 524
  • [6] Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases
    Przybylski, Grzegorz
    Chorostowska-Wynimko, Joanna
    Dyczek, Andrzej
    Wedrowska, Ewelina
    Jankowski, Marek
    Szpechcinski, Adam
    Gizycka, Agata
    Golinska, Joanna
    Kopinski, Piotr
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (04): : 260 - 271
  • [7] Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease
    Kim, Youlim
    Lee, Yeon Joo
    Cho, Young-Jae
    Yoon, Ho Il
    Lee, Jae Ho
    Lee, Choon-Taek
    Park, Jong Sun
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 246 (03): : 147 - 153
  • [8] Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis
    Hesselstrand, Roger
    Wildt, Marie
    Bozovic, Gracijela
    Andersson-Sjoland, Annika
    Andreasson, Kristofer
    Scheja, Agneta
    Westergren-Thorsson, Gunilla
    Bjermer, Leif
    Wuttge, Dirk M.
    RESPIRATORY MEDICINE, 2013, 107 (07) : 1079 - 1086
  • [9] An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
    Meyer, Keith C.
    Raghu, Ganesh
    Baughman, Robert P.
    Brown, Kevin K.
    Costabel, Ulrich
    du Bois, Roland M.
    Drent, Marjolein
    Haslam, Patricia L.
    Kim, Dong Soon
    Nagai, Sonoko
    Rottoli, Paola
    Saltini, Cesare
    Selman, Moises
    Strange, Charlie
    Wood, Brent
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (09) : 1004 - 1014
  • [10] Clinical Usefulness of Bronchoalveolar Lavage Cellular Analysis and Lymphocyte Subsets in Diffuse Interstitial Lung Diseases
    Lee, Wookeun
    Chung, Wha Soon
    Hong, Ki-Sook
    Huh, Jungwon
    ANNALS OF LABORATORY MEDICINE, 2015, 35 (02) : 220 - 225